IHS(IHS)
IHS
$8.46—
NYSE
$8.46—
Analyst ratings reflect Wall Street opinion, not guarantees. Historical accuracy varies by firm and sector.
Price targets are 12-month analyst forecasts. Actual results depend on earnings, market conditions, and sector trends.
| Metric | FY2026E | FY2027E | FY2028E | FY2029E | FY2030E |
|---|---|---|---|---|---|
| Revenue Avg | $1.79B | $1.75B | $1.86B | $2.17B | $2.33B |
| Low | $1.76B | $1.72B | $1.83B | $2.13B | $2.28B |
| High | $1.82B | $1.78B | $1.89B | $2.21B | $2.37B |
| EBITDA Avg | $1.11B | $1.14B | $1.21B | $1.17B | $1.25B |
| Low | $1.11B | $1.13B | $1.20B | $1.16B | $1.24B |
| High | $1.12B | $1.15B | $1.22B | $1.18B | $1.26B |
| EBIT Avg | $728M | $753M | $812M | $754M | $813M |
| Low | $720M | $745M | $802M | $745M | $802M |
| High | $736M | $761M | $822M | $761M | $822M |
| Net Income Avg | $266M | $287M | $334M | $287M | $335M |
| Low | $260M | $280M | $326M | $280M | $326M |
| High | $272M | $293M | $342M | $293M | $342M |
| EPS Avg | $0.78 | $0.84 | $0.98 | $0.84 | $0.98 |
| Low | $0.76 | $0.82 | $0.96 | $0.82 | $0.96 |
| High | $0.80 | $0.86 | $1.00 | $0.86 | $1.00 |
| Analysts (Rev / EPS) | 2 / 1 | 2 / 1 | 2 / 1 | 1 / 1 | 1 / 1 |
| Metric | Q3 2026 | Q4 2026 | Q1 2027 | Q2 2027 |
|---|---|---|---|---|
| Revenue Avg | $420M | $424M | $443M | $456M |
| Low | $420M | $424M | $443M | $456M |
| High | $420M | $424M | $443M | $456M |
| EBITDA Avg | $251M | $286M | $237M | $180M |
| Low | $251M | $286M | $237M | $180M |
| High | $251M | $286M | $237M | $180M |
| EBIT Avg | $191M | $225M | $174M | $115M |
| Low | $191M | $225M | $174M | $115M |
| High | $191M | $225M | $174M | $115M |
| Net Income Avg | $103M | $131M | $89M | $41M |
| Low | $103M | $131M | $89M | $41M |
| High | $103M | $131M | $89M | $41M |
| EPS Avg | $0.30 | $0.38 | $0.26 | $0.12 |
| Low | $0.30 | $0.38 | $0.26 | $0.12 |
| High | $0.30 | $0.38 | $0.26 | $0.12 |
| Analysts (Rev / EPS) | 1 / 1 | 1 / 1 | 1 / 1 | 1 / 1 |